111Category: | Pharmaceuticals and Biochemicals |
|
|
CAS NO: | 117976-90-6 | ||
EC NO: | 222-630-7 | ||
Molecular Formula: | C18H20N3NaO3S | ||
Molecular Weight: | 381.4245 | ||
Specification: | |||
InChI: | InChI=1/C18H20N3O3S.Na/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18;/h3-4,6-9H,5,10-12H2,1-2H3;/q-1;+1/rC18H20N3NaO3S/c1-13-15(19-9-8-17(13)25-11-5-10-24-2)12-26(23)18-20-14-6-3-4-7-16(14)21(18)22/h3-4,6-9H,5,10-12H2,1-2H3 | ||
Synonyms: | 2-[[[4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL]METHYL]SULFINYL]-1H-BENZIMIDAZOLE, SODIUM SALT;2-[[[4-(3-METHOXYPROPOXY)-3-METHYLPYRIDIN-2-YL]METHYL]SULFINY]-1H-BENZIMIDAZOLE SODIUM SALT;sodium 2-[[4-(3-methoxypropoxy)-3-methyl-pyridin-2-yl]methylsulfinyl]benzoimidazole;SODIUM RABEPRAZOLE;PARIET;RABEPRAZOLE SODIUM;RABEPRAZOLE, SODIUM SALT;(3,5-dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone;sodium 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfinyl)benzimidazol-1-ide;[2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfinyl]benzimidazol-1-yl]sodium; | ||
Molecular Structure: |